Pena–Shokeir syndrome
Pena–Shokeir syndrome is a rare genetic disorder characterized by a range of physical anomalies and developmental delays. It falls under the category of fetal akinesia deformation sequence (FADS), a group of conditions that result from reduced fetal movement. The syndrome is named after the researchers who first described it, Pena and Shokeir, in 1974.
Causes[edit | edit source]
Pena–Shokeir syndrome is caused by genetic mutations that affect fetal muscle movement. The exact genetic cause can vary among individuals, and in many cases, the specific mutation remains unidentified. The condition is inherited in an autosomal recessive manner, meaning that a child must inherit one copy of the mutated gene from each parent to be affected.
Symptoms[edit | edit source]
The syndrome is characterized by a wide range of symptoms, including:
- Fetal akinesia: Reduced fetal movement in the womb, leading to various physical deformities.
- Arthrogryposis: Joint contractures that are present at birth, affecting multiple areas of the body.
- Pulmonary hypoplasia: Underdevelopment of the lungs, which can lead to breathing difficulties after birth.
- Facial anomalies: These may include a narrow, sloping forehead, a nose with a broad tip, and a small jaw.
- Growth retardation: Affected individuals may have a low birth weight and experience slowed growth after birth.
Diagnosis[edit | edit source]
Diagnosis of Pena–Shokeir syndrome is primarily based on clinical observation and the presence of characteristic symptoms. Prenatal ultrasound may reveal reduced fetal movements and physical anomalies suggestive of the syndrome. Genetic testing can be helpful in confirming the diagnosis, especially if a specific mutation is identified.
Treatment[edit | edit source]
There is no cure for Pena–Shokeir syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include physical therapy to improve joint mobility, respiratory support for those with pulmonary hypoplasia, and surgical interventions to correct physical deformities. Early intervention and a multidisciplinary approach are crucial for addressing the complex needs of affected individuals.
Prognosis[edit | edit source]
The prognosis for individuals with Pena–Shokeir syndrome varies depending on the severity of symptoms. The condition can be life-threatening in severe cases, particularly when significant pulmonary hypoplasia is present. Many affected infants experience significant developmental delays and may require lifelong support and care.
See also[edit | edit source]
Pena–Shokeir syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD